本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Arcus Biosciences Inc.

8.25
-0.0500-0.60%
盘后8.250.00000.00%16:05 EDT
成交量:134.81万
成交额:1,110.48万
市值:8.73亿
市盈率:-2.63
高:8.46
开:8.29
低:8.12
收:8.30
数据加载中...
2021/03/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/24

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/02/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/01

重要事件披露

8-K - Current report
2021/01/06

重要事件披露

8-K - Current report
2020/12/18

重要事件披露

8-K - Current report
2020/12/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/05

重要事件披露

8-K - Current report
2020/11/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/10/15

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/10/01

重要事件披露

8-K - Current report
2020/08/06

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/06

重要事件披露

8-K - Current report